IGFBP2 and COVID-19: Among the nine COVID-19 non-survivors, no significant difference in IGFBP-2 levels was observed compared to the survivors, suggesting that IGFBP-2 might not reliably predict mortality in COVID-19 sepsis (p = 0.222).